SEC Form 4 · accession 0001019687-15-003338
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Surrey Barbari
Director
Period of report
Aug 31, 2015
Accepted (ET)
Sep 2, 2015 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Rights to Buy)F1 | $1.21 | Aug 31, 2015 | A | 5,109 | A | Aug 31, 2015 | Aug 31, 2025 | Common Stock | 5,109 | 76,048 | D |
Explanation of responses
- F1The options were granted by the Issuer pursuant to the Non-Employee Director Compensation Plan.